A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

G lucagon-like peptide-1 receptor agonists (GLP-1RA) drugs, such as Ozempic and Wegovy, are often referred to as "miracle ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

Researchers say GLP-1 medicines might be able to help with migraines.

This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...